BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kee K, Lu S. Diagnostic efficacy of ultrasound in hepatocellular carcinoma diagnosis. Expert Review of Gastroenterology & Hepatology 2017;11:277-9. [DOI: 10.1080/17474124.2017.1292126] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Mukhatov A, Le T, Pham TT, Do TD. A comprehensive review on magnetic imaging techniques for biomedical applications. Nano Select 2023. [DOI: 10.1002/nano.202200219] [Reference Citation Analysis]
2 Nakata N, Siina T. Ensemble Learning of Multiple Models Using Deep Learning for Multiclass Classification of Ultrasound Images of Hepatic Masses. Bioengineering (Basel) 2023;10. [PMID: 36671641 DOI: 10.3390/bioengineering10010069] [Reference Citation Analysis]
3 Sultan LR, Al-hasani M, Karmacharya MB, Cary TW, Sehgal CM. Contrast-enhanced ultrasound for assessing blood flow modulation of hepatocellular carcinoma by hydralazine. 2022 IEEE International Ultrasonics Symposium (IUS) 2022. [DOI: 10.1109/ius54386.2022.9958467] [Reference Citation Analysis]
4 Hu R, Liang X, Li Q, Liu Y, Shi Z. Risk Predictive Model Based on Three DDR-Related Genes for Predicting Prognosis, Therapeutic Sensitivity, and Tumor Microenvironment in Hepatocellular Carcinoma. Journal of Oncology 2022;2022:1-11. [DOI: 10.1155/2022/4869732] [Reference Citation Analysis]
5 Zhang A, Sun H, Wang X. The Application of Metabolomics in Cancer Management. Mass Spectrometry‐Based Metabolomics in Clinical and Herbal Medicines 2021. [DOI: 10.1002/9783527835751.ch8] [Reference Citation Analysis]
6 Marschner CA, Zhang L, Schwarze V, Völckers W, Froelich MF, von Münchhausen N, Schnitzer ML, Geyer T, Fabritius MP, Rübenthaler J, Clevert DA. The diagnostic value of contrast-enhanced ultrasound (CEUS) for assessing hepatocellular carcinoma compared to histopathology; a retrospective single-center analysis of 119 patients1. Clin Hemorheol Microcirc 2020;76:453-8. [PMID: 33216017 DOI: 10.3233/CH-209221] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
7 Kim J, Yun J, Kim K, Kim NI, Kim HJ, Lee J. Ex - Vivo Identification of Tumor From Parenchyma in Human Liver Using Electrochemical Impedance Spectroscopy on a Needle. IEEE Sensors J 2020;20:14042-9. [DOI: 10.1109/jsen.2020.3008722] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
8 Omar M, Farid K, Emran T, El-Taweel F, Tabll A, Omran M. HCC-Mark: a simple non-invasive model based on routine parameters for predicting hepatitis C virus related hepatocellular carcinoma. Br J Biomed Sci 2021;78:72-7. [PMID: 33016838 DOI: 10.1080/09674845.2020.1832371] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
9 Hu J, Zhou ZY, Ran HL, Yuan XC, Zeng X, Zhang ZY. Diagnosis of liver tumors by multimodal ultrasound imaging. Medicine (Baltimore) 2020;99:e21652. [PMID: 32769936 DOI: 10.1097/MD.0000000000021652] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
10 Wang JY, Feng SY, Yi AJ, Zhu D, Xu JW, Li J, Cui XW, Dietrich CF. Comparison of Contrast-Enhanced Ultrasound vs Contrast-Enhanced Magnetic Resonance Imaging for the Diagnosis of Focal Liver Lesions Using the Liver Imaging Reporting and Data System. Ultrasound Med Biol. 2020;46:1216-1223. [PMID: 32115307 DOI: 10.1016/j.ultrasmedbio.2020.01.023] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
11 Omran MM, Farid K, Omar MA, Emran TM, El-Taweel FM, Tabll AA. A combination of α-fetoprotein, midkine, thioredoxin and a metabolite for predicting hepatocellular carcinoma. Ann Hepatol 2020;19:179-85. [PMID: 31648804 DOI: 10.1016/j.aohep.2019.09.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
12 Brozzetti S, Bini S, D’alterio C, De Lucia C, Luca Chiarella L, Fazzi K, Di Martino M. HCC in Cirrhotic and Non-cirrhotic Liver: Timing to Surgery and Outcome - State of the Art. Liver Disease and Surgery [Working Title] 2019. [DOI: 10.5772/intechopen.86638] [Reference Citation Analysis]
13 Lee JY, Huo EJ, Weinstein S, Santos C, Monto A, Corvera CU, Yee J, Hope TA. Evaluation of an abbreviated screening MRI protocol for patients at risk for hepatocellular carcinoma. Abdom Radiol (NY) 2018;43:1627-33. [PMID: 29018942 DOI: 10.1007/s00261-017-1339-5] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 8.4] [Reference Citation Analysis]